Abstract
This is a very short interim report since, due to the stratification according to nodal status and the first random allocation to groups with and without radiotherapy, there are 16 subgroups among 310 patients available for analysis. For this reason, the EORTC expects no conclusive results before 2 additional years of follow-up. Nevertheless, some trends are beginning to appear that will be summarized below and should be considered as very preliminary.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Reference
Israel, L.: Nonspecific immunostimulation in bronchogenic cancer. Scand. J. Resp. Dis. [Suppl.] 89, 95–105 (1974).
Israel, L., Edelstein, R., Depierre, A., Dimitrov, N.: Daily intravenous infusions of Corynebacterium parvum in twenty patients with disseminated cancer: A preliminary report of clinical and biologic findings. J.N.C.I. 55, 29–33 (1975).
Israel, L.: Nonspecific immune stimulation with corynebacteria in lung cancer. In: Lung cancer. Natural history, prognosis, and therapy. Israël, L., Chahinian, P. (eds.), Vol. I, pp. 273-280. New York-London: Academic Press 1976.
Israel, L., Edelstein, R.: In vivo and in vitro studies on nonspecific blocking factors of host origin in cancer patients. Role of plasma exchange as an immunotherapeutic modality. Isr. J. Med. Sci. 14, 105–130 (1978).
Israel, L.: An immunological look at the TNM classification therapeutic implications and strategies. Cancer Treat. Rep. (1978) (in press).
McKneally, M. F., Maver, C., Kansel, H. W.: Regional immunotherapy of lung cancer with intrapleural BCG. Lancet 1976/I, 377-379.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1979 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Israel, L., Depierre, A., Sylvester, R. (1979). Preliminary Trends of the EORTC Study Comparing Postoperative Chemotherapy, Immunotherapy, Chemoimmunotherapy or Abstention in Squamous Cell Bronchial Carcinoma. In: Bonadonna, G., Mathé, G., Salmon, S.E. (eds) Adjuvant Therapies and Markers of Post-Surgical Minimal Residual Disease II. Recent Results in Cancer Research, vol 68. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-81332-0_39
Download citation
DOI: https://doi.org/10.1007/978-3-642-81332-0_39
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-81334-4
Online ISBN: 978-3-642-81332-0
eBook Packages: Springer Book Archive